Miltefosine Granted Orphan Drug Approval for Invasive Candidiasis
The US Food and Drug Administration (FDA) has granted orphan drug designation approval of miltefosine (Profounda, Inc) for the treatment […]
» Read moreHome »
Mucormycosis is an existing but rare fungal infection with continuous headache, heaviness in the facial area, or swelling as the […]
COVID-19 and mucormycosis fungal infection: All you need to know
